Redwood Wealth Management Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,165
Closed -$62.9K 365
2024
Q2
$62.9K Buy
+1,165
New +$62.9K 0.05% 268